AR039723A1 - COMBINATION THERAPY WHERE A SEROTONINE RECOVERY INHIBITOR IS USED - Google Patents
COMBINATION THERAPY WHERE A SEROTONINE RECOVERY INHIBITOR IS USEDInfo
- Publication number
- AR039723A1 AR039723A1 ARP030102208A ARP030102208A AR039723A1 AR 039723 A1 AR039723 A1 AR 039723A1 AR P030102208 A ARP030102208 A AR P030102208A AR P030102208 A ARP030102208 A AR P030102208A AR 039723 A1 AR039723 A1 AR 039723A1
- Authority
- AR
- Argentina
- Prior art keywords
- disorder
- disorders
- anxiety
- compound
- serotonin reuptake
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Uso de un compuesto, que es un inhibidor de recaptación de serotonina, y otro compuesto que es un antagonista del receptor GABAB, agonista inverso, o agonista parcial para la preparación de una composición farmacéutica para el tratamiento de depresión, trastornos de ansiedad y otros trastornos afectivos, tales como desorden de ansiedad generalizada como ansiedad al pánico, desorden compulsivo obsesivo, desorden de estrés agudo, desorden de estrés post-traumático y desorden de ansiedad social, trastornos de la alimentación tales como bulimia, anorexia y obesidad, fobias, distimias, síndrome pre-menstrual, trastornos cognitivos, trastornos del control del impulso, trastorno de hiperactividad, trastornos de hiperactividad de atención deficiente, abuso de drogas o cualquier otro trastorno que responda a los inhibidores de recaptación de serotonina. Reivindicación 12: Una composición farmacéutica que comprende un compuesto, que es un inhibidor de la recaptación de serotonina, y otro compuesto, que es un antagonista, agonista inverso o agonista parcial del receptor GABAB, y opcionalmente vehículos o diluyentes aceptables para uso farmacéutico.Use of a compound, which is a serotonin reuptake inhibitor, and another compound that is a GABAB receptor antagonist, inverse agonist, or partial agonist for the preparation of a pharmaceutical composition for the treatment of depression, anxiety disorders and other disorders affective, such as generalized anxiety disorder such as panic anxiety, obsessive compulsive disorder, acute stress disorder, post-traumatic stress disorder and social anxiety disorder, eating disorders such as bulimia, anorexia and obesity, phobias, dysthias, pre-menstrual syndrome, cognitive disorders, impulse control disorders, hyperactivity disorder, attention deficit hyperactivity disorders, drug abuse or any other disorder that responds to serotonin reuptake inhibitors. Claim 12: A pharmaceutical composition comprising a compound, which is a serotonin reuptake inhibitor, and another compound, which is an antagonist, inverse agonist or partial agonist of the GABAB receptor, and optionally acceptable carriers or diluents for pharmaceutical use.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200200943 | 2002-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR039723A1 true AR039723A1 (en) | 2005-03-09 |
Family
ID=36701304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030102208A AR039723A1 (en) | 2002-06-20 | 2003-06-20 | COMBINATION THERAPY WHERE A SEROTONINE RECOVERY INHIBITOR IS USED |
Country Status (8)
| Country | Link |
|---|---|
| CN (1) | CN101358379A (en) |
| AR (1) | AR039723A1 (en) |
| CO (1) | CO5680440A2 (en) |
| EA (1) | EA200401468A1 (en) |
| IS (1) | IS2444B (en) |
| SI (1) | SI1545552T1 (en) |
| UA (1) | UA81248C2 (en) |
| ZA (1) | ZA200409278B (en) |
-
2003
- 2003-06-19 CN CNA2008102158847A patent/CN101358379A/en active Pending
- 2003-06-19 EA EA200401468A patent/EA200401468A1/en unknown
- 2003-06-19 SI SI200330816T patent/SI1545552T1/en unknown
- 2003-06-19 UA UA20041210013A patent/UA81248C2/en unknown
- 2003-06-20 AR ARP030102208A patent/AR039723A1/en not_active Application Discontinuation
-
2004
- 2004-11-18 ZA ZA200409278A patent/ZA200409278B/en unknown
- 2004-11-26 IS IS7557A patent/IS2444B/en unknown
-
2005
- 2005-01-17 CO CO05003060A patent/CO5680440A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS2444B (en) | 2008-11-15 |
| UA81248C2 (en) | 2007-12-25 |
| SI1545552T1 (en) | 2007-08-31 |
| ZA200409278B (en) | 2006-04-26 |
| CN101358379A (en) | 2009-02-04 |
| EA200401468A1 (en) | 2005-04-28 |
| CO5680440A2 (en) | 2006-09-29 |
| IS7557A (en) | 2004-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME00039B (en) | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | |
| NO20055208L (en) | 4- (2-Phenylsulfanyl-phenyl) -piperidine derivatives as serotonin reuptake inhibitors | |
| CO5190662A1 (en) | HIGHLY SELECTIVE INHIBITORS OF NOREPINEFRINE RECOVERY AND METHODS OF USE OF THE SAME | |
| DK1238676T3 (en) | Combination of a serotonin reuptake inhibitor and an atypical antipsychotic for use in depression, obsessive-compulsive disorder and psychosis | |
| BRPI0518043A (en) | 4-phenyl substituted tetrahydroisoquinolines and use of these to block the reuptake of norepinephrine, dopamine and serotonin | |
| NO20060242L (en) | The combination of a serotonin reuptake inhibitor and agomelatine | |
| RU2012152922A (en) | TREATMENT OF PSYCHOLOGICAL CONDITIONS WITH THE USE OF M1-MUSCARINE RECEPTOR ANTAGONISTS | |
| PE20040924A1 (en) | ESCITALOPRAM BROMHYDRATE AND A METHOD FOR ITS PREPARATION | |
| DK1545552T3 (en) | Combination therapy using a serotin reuptake inhibitor | |
| AR026371A1 (en) | NEW FORMULATION, USE AND METHOD | |
| AR048134A1 (en) | THE COMBINATION OF AN INHIBITOR OF THE RECOVERY OF SEROTONINE AND AN ANTAGONIST OF THE RECEIVER OF HISTAMINE 3, THE INVESTED AGONIST OR THE PARTIAL AGONIST | |
| NO20063267L (en) | The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist | |
| AR047715A1 (en) | ANALEPTIC AND ANTDEPRESSIVE COMBINATIONS | |
| AR039723A1 (en) | COMBINATION THERAPY WHERE A SEROTONINE RECOVERY INHIBITOR IS USED | |
| MX2011012596A (en) | Methods of enhancing selective serotonin reuptake inhibitor effects in mammals. | |
| BRPI0413587A (en) | Uses of a Glyt-1 Compound and Inhibitor, Pharmaceutical Composition, Kit, and, Disease Treatment Method | |
| ATE370953T1 (en) | ANTIDEPRESSIVE INDOLALKYL DERIVATIVES OF HETEROCYCLIC CONDENSED BENZODIOXANE METHYLAMINES | |
| BR0314431A (en) | Antidepressant piperidine derivatives of heterocyl-fused benzodioxanes | |
| AR045284A1 (en) | USE OF AN INHIBITOR COMPOUND FOR SEROTONINE RECOVERY AND AN INHIBITOR COMPOUND OF THE TYPE I GLICINE CARRIER FOR DEPRESSION TREATMENT | |
| ATE423772T1 (en) | MORPHOLINE DERIVATIVES AS INHIBITORS OF NOREPINEPHRINE REUPSTRUCTION | |
| NO20060229L (en) | Gaboxadol for the treatment of depression and other affective disorders | |
| RU2009101143A (en) | TREATMENT OF PSYCHOLOGICAL CONDITIONS WITH THE APPLICATION OF ANTAGGONISTS OF M1-MUSCARINE RECEPTORS | |
| MX2022011479A (en) | Combination of atypical antipsychotic and serotonin reuptake inhibitor. | |
| SE9803155D0 (en) | A new composition | |
| CL2004000725A1 (en) | COMPOUNDS DERIVED FROM 4- (2-PHENYLSULPHANYLFENYL) PIPERIDINE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE TREATMENT OF AFFECTIVE DISORDERS such as DEPRESSION, ANXIETY DISORDERS, COMPULSIVE OBSESSIVE DISORDER, PANIC DISORDER, ATTACK |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |